Cypress Capital Group decreased its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 16.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,083 shares of the company’s stock after selling 2,259 shares during the period. Cypress Capital Group’s holdings in Express Scripts Holding were worth $731,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. First National Bank of Omaha raised its position in shares of Express Scripts Holding by 13.4% in the first quarter. First National Bank of Omaha now owns 13,665 shares of the company’s stock valued at $900,000 after buying an additional 1,620 shares in the last quarter. Regentatlantic Capital LLC raised its position in shares of Express Scripts Holding by 25.4% in the first quarter. Regentatlantic Capital LLC now owns 40,551 shares of the company’s stock valued at $2,673,000 after buying an additional 8,217 shares in the last quarter. Bank of Montreal Can raised its position in shares of Express Scripts Holding by 10.3% in the first quarter. Bank of Montreal Can now owns 639,289 shares of the company’s stock valued at $42,136,000 after buying an additional 59,666 shares in the last quarter. Legacy Private Trust Co. raised its position in shares of Express Scripts Holding by 2.7% in the first quarter. Legacy Private Trust Co. now owns 37,709 shares of the company’s stock valued at $2,485,000 after buying an additional 1,008 shares in the last quarter. Finally, Carroll Financial Associates Inc. raised its position in shares of Express Scripts Holding by 8.2% in the first quarter. Carroll Financial Associates Inc. now owns 3,156 shares of the company’s stock valued at $208,000 after buying an additional 238 shares in the last quarter. Hedge funds and other institutional investors own 90.20% of the company’s stock.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) traded down 0.82% on Monday, hitting $62.02. The stock had a trading volume of 328,067 shares. The company has a 50 day moving average of $63.15 and a 200-day moving average of $64.92. Express Scripts Holding Company has a 12-month low of $57.80 and a 12-month high of $77.61. The firm has a market capitalization of $35.82 billion, a P/E ratio of 10.76 and a beta of 0.90.

Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the firm posted $1.57 earnings per share. Equities analysts predict that Express Scripts Holding Company will post $6.99 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Cypress Capital Group Decreases Position in Express Scripts Holding Company (ESRX)” was first posted by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/07/cypress-capital-group-decreases-position-in-express-scripts-holding-company-esrx.html.

Several equities analysts recently issued reports on the company. Bank of America Corporation restated a “neutral” rating and set a $77.00 price target on shares of Express Scripts Holding in a research note on Tuesday, April 25th. Cowen and Company lowered their price target on Express Scripts Holding from $90.00 to $83.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 25th. SunTrust Banks, Inc. restated a “buy” rating on shares of Express Scripts Holding in a research note on Tuesday, April 25th. Mizuho lowered their price target on Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 25th. Finally, UBS AG set a $71.00 price target on Express Scripts Holding and gave the company a “hold” rating in a research note on Tuesday, April 25th. Four investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $70.81.

In related news, VP Phyllis S. Anderson sold 1,100 shares of Express Scripts Holding stock in a transaction that occurred on Friday, May 19th. The shares were sold at an average price of $60.08, for a total value of $66,088.00. Following the transaction, the vice president now directly owns 11,108 shares of the company’s stock, valued at $667,368.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.68% of the company’s stock.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.